Friday, May 12, 2006

New Vitamin A drug may cut breast cancer risk

Breakthrough Breast Cancer, a leading charity committed to fighting breast cancer through research and education in UK found that the drug Fenretinide reduced second cancers in pre-menopausal women by 38 per cent and halved the risk in those under 40. However, the cancer rate actually increased among post-menopausal women taking the drug, it said. Fenretinide is a synthetic version of Retinol or active vitamin A, which can combat certain types of tumour. --Click the title of this post to read the full article from its source--

0 Comments:

Post a Comment

<< Home

/* WebRing Code */